Cargando…

Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis

PURPOSE: To review the management of gastrointestinal symptoms in patients with hereditary transthyretin amyloidosis, discussing diagnostic evaluations, assessment of disease progression and therapeutic strategies that could be implemented in routine practice. METHODS: Literature review. Key search...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obici, Laura, Suhr, Ole B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763516/ https://www.ncbi.nlm.nih.gov/pubmed/31452022 http://dx.doi.org/10.1007/s10286-019-00628-6

Ejemplares similares

Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis
por: Bentellis, Imad, et al.
Publicado: (2019)

Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
por: Kapoor, Mahima, et al.
Publicado: (2019)

Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP
por: Parman, Yesim, et al.
Publicado: (2016)

Preliminary assessment of neuropathy progression in patients with hereditary ATTR amyloidosis after orthotopic liver transplantation (OLT)
por: Adams, David, et al.
Publicado: (2015)

Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis
por: Obici, Laura, et al.
Publicado: (2016)

Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR
por: Yarlas, Aaron, et al.
Publicado: (2021)

Ocular Involvement in Hereditary Amyloidosis
por: Minnella, Angelo Maria, et al.
Publicado: (2021)

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis
por: Niemietz, Christoph, et al.
Publicado: (2015)

Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
por: Brannagan, Thomas H., et al.
Publicado: (2022)

Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis
por: Wixner, Jonas, et al.
Publicado: (2015)

Motor Conduction Studies and Handgrip in Hereditary TTR Amyloidosis: Simple Tools to Evaluate the Upper Limbs
por: Di Stefano, Vincenzo, et al.
Publicado: (2022)

SOM0226, a repositioned compound for the treatment of TTR amyloidosis
por: Reig, Núria, et al.
Publicado: (2015)

Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis
por: Iorio, Andrea, et al.
Publicado: (2017)

Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy
por: Damy, Thibaud, et al.
Publicado: (2016)

Treatment of gastrointestinal complication in transthyretin amyloidosis. A single centre’s experience
por: Suhr, Ole B
Publicado: (2015)

Non-invasive risk stratification of patients with TTR amyloidosis
por: Scherer, Katrin A, et al.
Publicado: (2013)

The phenotypical expression of an European inherited TTR amyloidosis in Brazil
por: Cruz, Márcia Waddington, et al.
Publicado: (2015)

TTR amyloidosis: a scientific journey since Andrade
por: Saraiva, Maria João
Publicado: (2015)

Neuropathology of central nervous system involvement in TTR amyloidosis
por: Taipa, Ricardo, et al.
Publicado: (2022)

TTR Amyloidosis: Current State of Affairs and Promise for the Future
por: Brailovsky, Yevgeniy, et al.
Publicado: (2023)

Guideline of transthyretin-related hereditary amyloidosis for clinicians
por: Ando, Yukio, et al.
Publicado: (2013)

MALDI spectrometry for salivary samples analysis : a new tool for TTR amyloidosis diagnosis
por: Seguier, Julie, et al.
Publicado: (2015)

Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction
por: Goland, Sorel, et al.
Publicado: (2021)

Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study
por: Yarlas, Aaron, et al.
Publicado: (2021)

Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis
por: Puig-Carrion, Gisela D., et al.
Publicado: (2019)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

Delayed small bowel octreotide response in patients with hereditary transthyretin amyloidosis
por: Jonas, Wixner, et al.
Publicado: (2015)

Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy
por: Cortese, Andrea, et al.
Publicado: (2017)

Four-Chamber Intracardiac Thrombi Complicating Wild-Type TTR Amyloidosis
por: Griffin, Jan M., et al.
Publicado: (2018)

TTR Gly83Arg Mutation: Beyond Familial Vitreous Amyloidosis
por: Li, Zhenxian, et al.
Publicado: (2022)

Cardiac Amyloidosis: A Rare TTR Mutation Found in an Asian Female
por: Mouksian, Kristina, et al.
Publicado: (2023)

Burden of hereditary transthyretin amyloidosis on quality of life
por: Yarlas, Aaron, et al.
Publicado: (2019)

Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group
por: Mauermann, Michelle L., et al.
Publicado: (2023)

Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia
por: Ziskin, Jennifer L., et al.
Publicado: (2015)

Amyloidosis due to TTR mutations in Mexico with 4 distincts genotypes in the index cases
por: González-Duarte, Alejandra, et al.
Publicado: (2018)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
por: Bemporad, Francesco, et al.
Publicado: (2022)

(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis
por: Pilebro, Björn, et al.
Publicado: (2016)

Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
por: Benson, Merrill D, et al.
Publicado: (2015)

Uptake of Aggregating Transthyretin by Fat Body in a Drosophila Model for TTR-Associated Amyloidosis
por: Pokrzywa, Malgorzata, et al.
Publicado: (2010)

Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition
por: Arvidsson, Sandra, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6si3m5kop95bqbc7al6mmujf7u